Printer Friendly

Mentor Receives European Approval for Silicone Gel Breast Implant Product Line Extension.

Business Editors/Health/Medical Writers

SANTA BARBARA, Calif.--(BUSINESS WIRE)--June 3, 2004

Mentor Corporation (NYSE:MNT):

-- CPG Plus Tall Silicone Breast Implant Used in Breast

Reconstruction and Breast Augmentation

-- Approval Further Enhances Product Offering in Europe and

Complements CPG Plus Low Breast Implant Approved in March 2004

Mentor Corporation (NYSE:MNT), a leading supplier of medical products in the United States and internationally, today announced that it had been notified that the Company's new tall height, Contour Profile(R) Moderate Plus Gel (CPG Plus Tall) breast implant had received European Union class III CE Mark approval.

This market-driven product offering further enhances Mentor's Elite(TM) silicone gel product family selection in Europe and complements the low height, Contour Profile(R) Moderate Plus Gel breast implant which was approved in Europe in March 2004. In Europe, Mentor offers round and shaped breast implants filled with the Company's exclusive Memory Gel(TM), as well as saline-filled breast implants, the Becker implants for single-stage breast reconstruction and a range of innovative tissue expanders.

"As with our recently approved low height CPG product, surgeons and patients had requested that we introduce this new, anatomically shaped, tall height breast implant with higher projection," commented Joshua H. Levine, President and Chief Executive Officer. "We will continue to extend our leadership position in international markets and in the United States by launching high-quality product line extensions that provide smart and effective solutions that add value for our customers and the patients they serve."

About Memory Gel

Mentor's advanced Memory Gel(TM) is a proprietary cohesive silicone gel formulation used to fill all of Mentor's Elite(TM) silicone gel-filled breast implants around the world. By varying the components of the gel, Mentor is able to produce a wide selection of gel-filled products ranging from a very soft to a very firm consistency.

About Contour Profile Gel Breast Implants

Mentor's Contour Profile(R) gel family of products is shaped to imitate the contour of the breast and provide shape retention with a pleasing level of firmness for optimal aesthetic results. These innovative products provide plastic surgeons with a smart and simple solution to selecting the optimal size and shape of implant for patients.

About Mentor Corporation

Founded in 1969, Mentor Corporation is a leading supplier of medical products for the global healthcare market. The Company develops, manufactures and markets innovative, science-based products for the aesthetics and urologic specialties markets around the world.

The Company's Aesthetics franchise includes prosthetic mammary implants for breast augmentation and reconstruction, and lipoplasty products for body contouring. Mentor's Urologic Specialties franchise includes surgical slings for the treatment of urinary stress incontinence, brachytherapy seeds for the treatment of prostate cancer, prosthetic implants for the treatment of erectile dysfunction and disposable medical devices for the treatment and care of urinary incontinence and other urological conditions.

Mentor continues to launch important line extensions to its existing products that add value to doctors and patients. In addition, the Company has made a number of strategic acquisitions and established key partnerships to expand its product portfolio. Mentor has leveraged its leadership position in aesthetics to expand into the cosmetic dermatology market through two development programs. The Company has acquired a range of next-generation, non-animal, synthetic hyaluronic acid-based dermal filler products. Mentor has also acquired broad rights to a range of highly purified, next-generation botulinum toxin products. Additionally, Mentor continues to expand its product portfolio through internal innovation.

Mentor employs approximately 2000 people around the world and is headquartered in Santa Barbara, with manufacturing and research operations in the United States, France, the Netherlands and the United Kingdom. The Company's website is www.mentorcorp.com.

Safe Harbor Statement

All statements included or incorporated by reference in this release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and projections about our industry, management's beliefs, and certain assumptions made by us. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," similar expressions, and variations or negatives of these words. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements speak only as of the date hereof and are based upon the information available to us at this time. Such information is subject to change, and we will not necessarily inform you of such changes. These statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statement as a result of various factors.

The Securities and Exchange Commission filings of Mentor, including, without limitation, its Annual Reports on Form 10-K, subsequent quarterly reports on Form 10-Q, and recent Current Reports on Form 8-K, discuss important risk factors that could contribute to such differences or otherwise affect its business, results of operations and financial condition. Mentor undertakes no obligation to revise or update publicly any forward-looking statement for any reason.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 3, 2004
Words:857
Previous Article:Vignette Customer to Highlight Award-Winning Portal at E-Gov Government Solutions Forum; Director of E-Michigan to Discuss Keys to Effective...
Next Article:BFG Technologies Expands into Europe with PC Enthusiast Products at PC World / Dixons.
Topics:


Related Articles
Breast implants, Hippocrates, and burden of proof.
A confederacy of boobs.
Breast implant makers offer new settlement; Dow Chemical stays out.
SURGICAL RISKS OF IMPLANTS.
ILLNESS AND CONDITIONS ELSEWHERE IN THE BODY AND BREAST IMPLANTS.
AVAILABILITY OF IMPLANTS.
FDA study shows silicone breast implants rupture more than previously thought.
FDA MAY LIFT BAN ON SILICONE BREAST IMPLANTS TRACKING RECIPIENTS' HEALTH FOR 10 YEARS RECOMMENDED.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters